Both of the shots are bivalent, targeting the original 2019 strain as well as BA.4 and BA.5, which today account for 96% of new COVID-19 infections in the United States.
Pfizer and BioNTech announced Monday morning they have applied for emergency use authorization from the Food and Drug Administration for COVID-19 booster shots that target the BA.4 and BA.5 omicron subvariants in children ages 5 to 11.Pfizer and BioNTech announced Monday morning they have applied for emergency use authorization from the Food and Drug Administration for COVID-19 booster shots that target the BA.4 and BA.
The shots would be a dosage of 10 micrograms — a third of what is given to adults and consistent with the existing vaccine dosage for kids that age The shots would be a dosage of 10 micrograms — a third of what is given to adults and consistent with the existing vaccine dosage for kids that age.
Canada Latest News, Canada Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Pfizer Asks FDA to Authorize Omicron Covid Booster Shots for Kids Ages 5 to 11Pfizer’s application to the FDA comes before clinical trial results of the omicron BA.5 booster shots have been published.
Read more »
The FDA investigated the ongoing baby formula shortage. Here's what it found.The FDA has struggled managing baby formula shortages after bacteria was found in products. Experts weigh in on unresolved issues.
Read more »
Scientists: Eat More of This Carb – Even Supplements Make a Big DifferenceThe human gut evolved to thrive on fermentable fibers, not burgers. It might be daunting for customers to choose from the vast selection of dietary fiber supplements in the pharmacy or supermarket aisle. They also offer a variety of health claims without being subject to FDA approval or review. How
Read more »
Pfizer Asks FDA to Authorize Omicron Covid Booster Shots for Kids Ages 5 to 11Pfizer’s application to the FDA comes before clinical trial results of the omicron BA.5 booster shots have been published.
Read more »